Ensign Peak Advisors »

Aerovate Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Aerovate Therapeutics (AVTE) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Aerovate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aerovate Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aerovate Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.8M 262k 29.57
2023-09-30 $204k 15k 13.57
2023-06-30 $257k 15k 17.15
2023-03-31 $303k 15k 20.17
2022-12-31 $621k 21k 29.30